- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
Inj. K MM
Injection
Generic Name
Phytomenadione
Manufacturer
Incepta Pharmaceuticals Ltd.
Unit Price
2 mg ampoule: ৳ 19.89 (1 x 5: ৳ 99.45)
🔹 Indications
Inj. K MM (Vitamin K-1) is indicated in following indications-
🔹 Pharmacology
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Dosage & Administration
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Interaction
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Contraindications
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Side Effects
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Precautions & Warnings
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
🔹 Storage Conditions
Inj. K MM (Vitamin K-1) is indicated in following indications-
- Prophylaxis and treatment of haemorrhagic disease in the newborn.
- Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VII, IX and X) of various etiologies, including overdosage of courmarin-type anticoagulants, their combination with phenylbutazone, and other forms of hypovitaminosis K (e.g. in obstructive jaundice as well as liver and intestinal disorders, and after prolonged treatment with antibiotics, sulphonamides or salicylates).
- Prevention and treatment of bleeding due to vitamin K deficiency.
💡 Frequently Asked Questions
Inj. K MM (Vitamin K-1) is indicated in following indications-
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VI...
Inj. K MM (Vitamin K-1) is indicated in following indications-
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VI...
Inj. K MM (Vitamin K-1) is indicated in following indications-
Prophylaxis and treatment of haemorrhagic disease in the newborn.
Haemorrhage or risk of haemorrhage as a result of severe hypoprothrombinemia (i.e. deficiency of clotting factors II, VI...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.